BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38642956)

  • 1. Prevalence and prognostic meaning of interstitial lung abnormalities in remote CT scans of patients with interstitial lung disease treated with antifibrotic therapy.
    García Mullor MM; Arenas-Jiménez JJ; Ureña Vacas A; Gayá García-Manso I; Pérez Pérez JL; Serra Serra N; García Sevila R
    Radiologia (Engl Ed); 2024 Apr; 66 Suppl 1():S10-S23. PubMed ID: 38642956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiologic-pathologic correlation of interstitial lung abnormalities and predictors for progression and survival.
    Chae KJ; Chung MJ; Jin GY; Song YJ; An AR; Choi H; Goo JM
    Eur Radiol; 2022 Apr; 32(4):2713-2723. PubMed ID: 34984519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and Early Referral of Patients With Interstitial Lung Abnormalities: An Expert Survey Initiative.
    Hunninghake GM; Goldin JG; Kadoch MA; Kropski JA; Rosas IO; Wells AU; Yadav R; Lazarus HM; Abtin FG; Corte TJ; de Andrade JA; Johannson KA; Kolb MR; Lynch DA; Oldham JM; Spagnolo P; Strek ME; Tomassetti S; Washko GR; White ES;
    Chest; 2022 Feb; 161(2):470-482. PubMed ID: 34197782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JOURNAL CLUB: Evidence of Interstitial Lung Disease on Low-Dose Chest CT Images: Prevalence, Patterns, and Progression.
    Salvatore M; Henschke CI; Yip R; Jacobi A; Eber C; Padilla M; Knoll A; Yankelevitz D
    AJR Am J Roentgenol; 2016 Mar; 206(3):487-94. PubMed ID: 26700157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline Characteristics and Progression of a Spectrum of Interstitial Lung Abnormalities and Disease in Rheumatoid Arthritis.
    Kawano-Dourado L; Doyle TJ; Bonfiglioli K; Sawamura MVY; Nakagawa RH; Arimura FE; Lee HJ; Rangel DAS; Bueno C; Carvalho CRR; Sabbag ML; Molina C; Rosas IO; Kairalla RA
    Chest; 2020 Oct; 158(4):1546-1554. PubMed ID: 32428513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Resolution CT Scan Fibrotic Patterns in Stage IV Pulmonary Sarcoidosis: Impact on Pulmonary Function and Survival.
    Obi ON; Alqalyoobi S; Maddipati V; Lower EE; Baughman RP
    Chest; 2024 Apr; 165(4):892-907. PubMed ID: 37879560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computed Tomography Honeycombing Identifies a Progressive Fibrotic Phenotype with Increased Mortality across Diverse Interstitial Lung Diseases.
    Adegunsoye A; Oldham JM; Bellam SK; Montner S; Churpek MM; Noth I; Vij R; Strek ME; Chung JH
    Ann Am Thorac Soc; 2019 May; 16(5):580-588. PubMed ID: 30653927
    [No Abstract]   [Full Text] [Related]  

  • 8. Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate.
    Jin GY; Lynch D; Chawla A; Garg K; Tammemagi MC; Sahin H; Misumi S; Kwon KS
    Radiology; 2013 Aug; 268(2):563-71. PubMed ID: 23513242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased monocyte level is a risk factor for radiological progression in patients with early fibrotic interstitial lung abnormality.
    Achaiah A; Lyon P; Fraser E; Saunders P; Hoyles R; Benamore R; Ho LP
    ERJ Open Res; 2022 Jul; 8(3):. PubMed ID: 35795307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated CT quantification of interstitial lung abnormality and interstitial lung disease according to the Fleischner Society in patients with resectable lung cancer: prognostic significance.
    Ahn Y; Lee SM; Choi S; Lee JS; Choe J; Do KH; Seo JB
    Eur Radiol; 2023 Nov; 33(11):8251-8262. PubMed ID: 37266656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interstitial lung abnormalities in a large clinical lung cancer screening cohort: association with mortality and ILD diagnosis.
    Patel AS; Miller E; Regis SM; Hunninghake GM; Price LL; Gawlik M; McKee AB; Rieger-Christ KM; Pinto-Plata V; Liesching TN; Wald C; Hashim J; McKee BJ; Gazourian L
    Respir Res; 2023 Feb; 24(1):49. PubMed ID: 36782326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Traction Bronchiectasis/Bronchiolectasis on CT Scans in Relationship to Clinical Outcomes and Mortality: The COPDGene Study.
    Hata A; Hino T; Putman RK; Yanagawa M; Hida T; Menon AA; Honda O; Yamada Y; Nishino M; Araki T; Valtchinov VI; Jinzaki M; Honda H; Ishigami K; Johkoh T; Tomiyama N; Christiani DC; Lynch DA; San José Estépar R; Washko GR; Cho MH; Silverman EK; Hunninghake GM; Hatabu H;
    Radiology; 2022 Sep; 304(3):694-701. PubMed ID: 35638925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of traction bronchiectasis/bronchiolectasis in interstitial lung abnormalities is associated with increased all-cause mortality: Age Gene/Environment Susceptibility-Reykjavik Study.
    Hino T; Hida T; Nishino M; Lu J; Putman RK; Gudmundsson EF; Hata A; Araki T; Valtchinov VI; Honda O; Yanagawa M; Yamada Y; Kamitani T; Jinzaki M; Tomiyama N; Ishigami K; Honda H; San Jose Estepar R; Washko GR; Johkoh T; Christiani DC; Lynch DA; Gudnason V; Gudmundsson G; Hunninghake GM; Hatabu H
    Eur J Radiol Open; 2021; 8():100334. PubMed ID: 33748349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subpleural fibrotic interstitial lung abnormalities are implicated in non-small cell lung cancer radiotherapy outcomes.
    Ito M; Katano T; Okada H; Sakuragi A; Minami Y; Abe S; Adachi S; Oshima Y; Ohashi W; Kubo A; Fukui T; Ito S; Suzuki K
    Radiol Oncol; 2023 Jun; 57(2):229-238. PubMed ID: 37078697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Traction Bronchiectasis/Bronchiolectasis is Associated with Interstitial Lung Abnormality Mortality.
    Hida T; Nishino M; Hino T; Lu J; Putman RK; Gudmundsson EF; Araki T; Valtchinov VI; Honda O; Yanagawa M; Yamada Y; Hata A; Jinzaki M; Tomiyama N; Honda H; Estepar RSJ; Washko GR; Johkoh T; Christiani DC; Lynch DA; Gudnason V; Gudmundsson G; Hunninghake GM; Hatabu H
    Eur J Radiol; 2020 Aug; 129():109073. PubMed ID: 32480316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Progression of Radiologic Abnormalities in Individuals at Risk for Familial Interstitial Lung Disease.
    Salisbury ML; Hewlett JC; Ding G; Markin CR; Douglas K; Mason W; Guttentag A; Phillips JA; Cogan JD; Reiss S; Mitchell DB; Wu P; Young LR; Lancaster LH; Loyd JE; Humphries SM; Lynch DA; Kropski JA; Blackwell TS
    Am J Respir Crit Care Med; 2020 May; 201(10):1230-1239. PubMed ID: 32011901
    [No Abstract]   [Full Text] [Related]  

  • 17. An observational cohort study of interstitial lung abnormalities (ILAs) in a large Japanese health screening population (Kumamoto ILA study in Japan: KILA-J).
    Ichikado K; Ichiyasu H; Iyonaga K; Kawamura K; Higashi N; Johkoh T; Fujimoto K; Morinaga J; Yoshida M; Mitsuzaki K; Suga M; Tanabe N; Handa T; Hirai T; Sakagami T
    BMC Pulm Med; 2023 Jun; 23(1):199. PubMed ID: 37291485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, imaging, and blood biomarkers to assess 1-year progression risk in fibrotic interstitial lung diseases-Development and validation of the honeycombing, traction bronchiectasis, and monocyte (HTM)-score.
    Shao G; Hawle P; Akbari K; Horner A; Hintenberger R; Kaiser B; Lamprecht B; Lang D
    Front Med (Lausanne); 2022; 9():1043720. PubMed ID: 36465895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practice patterns in reporting interstitial lung abnormality at a tertiary academic medical center.
    Escalon JG; Podolanczuk AJ; Aronson KI; Legasto AC; Gruden JF; Lynch DA; Rachid L; Rabkova Y; Steinberger S
    Clin Imaging; 2023 Dec; 104():109996. PubMed ID: 37862912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and Long-term Outcomes of CT Interstitial Lung Abnormalities in a Health Screening Cohort.
    Lee JE; Chae KJ; Suh YJ; Jeong WG; Lee T; Kim YH; Jin GY; Jeong YJ
    Radiology; 2023 Feb; 306(2):e221172. PubMed ID: 36219115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.